+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurovascular Intervention Devices Market - Global Forecast 2025-2030- Product Image
Neurovascular Intervention Devices Market - Global Forecast 2025-2030- Product Image
Sale

Neurovascular Intervention Devices Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674201
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neurovascular intervention devices market is undergoing significant transformation as healthcare providers and medical device companies strive to address the increasing complexity of cerebrovascular diseases with advanced, minimally invasive technologies. Senior decision-makers navigating this space require solid market intelligence to guide product development, strategic investments, and regulatory planning in this fast-evolving therapeutic area.

Market Snapshot: Neurovascular Intervention Devices

The Neurovascular Intervention Devices Market grew from USD 4.25 billion in 2024 to USD 4.53 billion in 2025. It is expected to continue growing at a CAGR of 6.52%, reaching USD 6.21 billion by 2030. This robust trajectory highlights increasing demand for state-of-the-art devices targeting aneurysms, arteriovenous malformations, and acute stroke. Market expansion is driven by greater awareness of the benefits of rapid intervention and by broader adoption across hospitals, clinics, and ambulatory centers worldwide.

Scope & Segmentation

This report provides comprehensive coverage, analyzing market trends and revenue forecasts across core product categories, major clinical applications, and key end users, as well as regional performance. Segmentation includes:

  • Product Type: Embolic agents (liquid embolics, particulate embolics), flow diverters (pipeline embolization device, surpass flow diverter), microcatheters (hydrophilic coated, polymer coated), neurovascular coils (detachable coils, pushable coils), stents (balloon mounted, self expanding), and thrombectomy devices (aspiration devices, stent retriever).
  • Indication: Aneurysm, arteriovenous malformation, and stroke.
  • End User: Ambulatory centers, clinics, and hospitals.
  • Procedure Type: Embolization, flow diversion, and thrombectomy.
  • Regions: Americas (including the United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (incorporating key markets such as United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, the Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Stryker Corporation, Medtronic plc, Johnson & Johnson, Penumbra Inc., Boston Scientific Corporation, Terumo Corporation, Becton Dickinson and Company, MicroPort Scientific Corporation, MicroVention Inc., Kaneka Corporation.

Key Takeaways for Senior Decision-Makers

  • Recent innovations focus on device flexibility, controlled occlusion, and precision delivery, supporting better patient outcomes and reduced procedural risks.
  • Integration of artificial intelligence in imaging enables real-time vessel assessment and navigation, supporting the shift toward personalized and precision-driven interventions.
  • Market players increasingly depend on cross-sector collaborations—even across borders—to accelerate device development, clinical validation, and efficient market entry.
  • New digital health platforms facilitate remote procedure monitoring and patient engagement, expanding the continuum of care beyond traditional settings.
  • Regional growth varies: mature healthcare markets favor advanced neurovascular techniques, while emerging regions prioritize infrastructure and pricing strategies.
  • Strategic investments in research, multidisciplinary stroke teams, and hybrid operating environments remain pivotal for sustaining market leadership and driving long-term growth.

Tariff Impact: Navigating 2025 Regulatory Headwinds

New United States tariffs on imported medical components in 2025 heightened operational complexity for device manufacturers, resulting in cost pressures and reorganization of global supply chains. Companies responded by renegotiating supplier agreements, exploring domestic sourcing, and accelerating shifts to local manufacturing partners. These measures affected procurement strategies, quality controls, and intellectual property management, while prompting healthcare providers to reassess cost structures for neurovascular procedures. Despite these challenges, many firms have leveraged the period to enhance process efficiencies and redesign their device portfolios for improved production agility.

Methodology & Data Sources

The analysis is built on a mixed-method research framework. Primary research comprised interviews with interventional neuroradiologists, procurement leaders, and clinical trial experts from major healthcare regions. Secondary data incorporates peer-reviewed journals, regulatory databases, conference material, and patent filings. Data triangulation was applied to ensure findings are robust and actionable for executive-level planning.

Why This Report Matters

  • Delivers a clear strategic assessment of emerging trends, competitive dynamics, and actionable growth opportunities within the neurovascular intervention devices market.
  • Informs C-level executives on aligning R&D, supply chain, and sales strategy with shifting clinical, regulatory, and economic environments.
  • Supports better investment and resource allocation decisions by mapping technology advancements and evolving regional market characteristics.

Conclusion

An in-depth, evidence-based analysis equips senior leadership to adapt to market changes, foster innovation, and optimize product portfolios for sustained success in neurovascular interventions. The report synthesizes trends, risks, and opportunities to support confident strategic decision-making.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of flow diversion devices for complex intracranial aneurysm treatment improving long-term occlusion rates
5.2. Advances in biodegradable embolic materials reducing risk of chronic inflammation and aiding vessel remodeling
5.3. Integration of real-time robotic-assisted neurovascular navigation systems enhancing procedural precision and safety
5.4. Development of next-generation thin-walled stents for improved vessel conformability and reduced thrombogenicity
5.5. Implementation of artificial intelligence-driven imaging analytics for optimized endovascular procedure planning
5.6. Rise in demand for microcatheters with improved torque control to navigate tortuous cerebral vasculature effectively
5.7. Expansion of hybrid operating room suites combining CT angiography and fluoroscopy to streamline neurointerventions
5.8. Growth in minimally invasive liquid embolic agents enabling targeted vascular occlusion with lower risk profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurovascular Intervention Devices Market, by Product Type
8.1. Introduction
8.2. Embolic Agents
8.2.1. Liquid Embolics
8.2.2. Particulate Embolics
8.3. Flow Diverters
8.3.1. Pipeline Embolization Device
8.3.2. Surpass Flow Diverter
8.4. Microcatheters
8.4.1. Hydrophilic Coated
8.4.2. Polymer Coated
8.5. Neurovascular Coils
8.5.1. Detachable Coils
8.5.2. Pushable Coils
8.6. Stents
8.6.1. Balloon Mounted
8.6.2. Self Expanding
8.7. Thrombectomy Devices
8.7.1. Aspiration Devices
8.7.2. Stent Retriever
9. Neurovascular Intervention Devices Market, by Indication
9.1. Introduction
9.2. Aneurysm
9.3. Arteriovenous Malformation
9.4. Stroke
10. Neurovascular Intervention Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Centers
10.3. Clinics
10.4. Hospitals
11. Neurovascular Intervention Devices Market, by Procedure Type
11.1. Introduction
11.2. Embolization
11.3. Flow Diversion
11.4. Thrombectomy
12. Americas Neurovascular Intervention Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neurovascular Intervention Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neurovascular Intervention Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Stryker Corporation
15.3.2. Medtronic plc
15.3.3. Johnson & Johnson
15.3.4. Penumbra, Inc.
15.3.5. Boston Scientific Corporation
15.3.6. Terumo Corporation
15.3.7. Becton, Dickinson and Company
15.3.8. MicroPort Scientific Corporation
15.3.9. MicroVention, Inc.
15.3.10. Kaneka Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET: RESEARCHAI
FIGURE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. NEUROVASCULAR INTERVENTION DEVICES MARKET: RESEARCHCONTACTS
FIGURE 26. NEUROVASCULAR INTERVENTION DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PIPELINE EMBOLIZATION DEVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PIPELINE EMBOLIZATION DEVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SURPASS FLOW DIVERTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SURPASS FLOW DIVERTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY POLYMER COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DETACHABLE COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DETACHABLE COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PUSHABLE COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PUSHABLE COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON MOUNTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON MOUNTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SELF EXPANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 130. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 131. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 132. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 133. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 134. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 135. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 136. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 137. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 138. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 139. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 140. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 141. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 262. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 263. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
TABLE 276. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2025-2030 (USD MILLION)
TABLE 277. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 282. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 283. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018

Samples

Loading
LOADING...

Companies Mentioned

  • Stryker Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Penumbra, Inc.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Becton, Dickinson and Company
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Kaneka Corporation

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.53 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.21 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Neurovascular Neurology Devices Market - Global Forecast 2025-2030 - Product Image

Neurovascular Neurology Devices Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Flow Diverters Market - Global Forecast 2025-2030 - Product Image

Flow Diverters Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Flow Diverters Global Market Report 2025 - Product Image

Flow Diverters Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033 - Product Image

Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033

  • Report
  • 143 Pages
  • Global
From
Neurovascular Devices / Interventional Neurology - Global Strategic Business Report - Product Image

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From

About the Neurovascular Intervention Device Market

The Neurovascular Intervention Device market is a subset of the Neurology Devices market, which includes a range of medical devices used to diagnose and treat neurological conditions. Neurovascular Intervention Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to access the brain and other parts of the nervous system, and to deliver treatments such as stents, balloons, and coils. The Neurovascular Intervention Device market is highly competitive, with a range of companies offering a variety of products. Some of the major players in the market include Medtronic, Stryker, Johnson & Johnson, Boston Scientific, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.